Related Experiment Video
Updated: May 9, 2026
07:37
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
The Global Rheumatology Workforce: Challenges and Considerations
Evelyn Hsieh1, Farhanah Paruk2, Sakir Ahmed3
1Section of Rheumatology, Allergy & Immunology, Yale University, New Haven, CT, USA; Section of Rheumatology, VA Connecticut Healthcare System, West Haven, CT, USA.
Rheumatic Diseases Clinics of North America
|May 7, 2026
Summary
Rheumatologic diseases cause widespread disability, yet specialist shortages hinder care, particularly in low-resource nations. Expanding training and leveraging technology are crucial to address this global health challenge.
Area of Science:
- Rheumatology
- Musculoskeletal Diseases
- Global Health
Background:
- Rheumatologic and musculoskeletal diseases are leading causes of global disability.
- Advanced therapeutics and subspecialty care are often required for these conditions.
- A significant shortage of trained rheumatology specialists exists worldwide, impacting patient care.
Purpose of the Study:
- To identify the challenges in rheumatology workforce training and subspecialty care access.
- To propose strategies for expanding the rheumatology workforce and improving care delivery.
- To highlight the role of technology in training and remote specialist access.
Main Methods:
- Literature review and analysis of global rheumatology workforce challenges.
- Examination of current training program limitations.
- Assessment of technological solutions for medical education and patient care.
Main Results:
- Insufficient training opportunities are a primary driver of specialist shortages, especially in low-resource settings.
- Existing training programs are inadequate to meet the demand for rheumatology specialists.
- Technology offers potential solutions for both training and extending specialist reach.
Conclusions:
- Expanding rheumatology training programs is essential to address workforce shortages.
- Improving academic career fulfillment can attract and retain specialists.
- Technology adoption is vital for enhancing training and increasing access to rheumatology care in underserved areas.
Related Concept Videos
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
01:23Rheumatic Heart Disease I: Introduction
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
01:20Rheumatic Heart Disease IV: Nursing Management
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
01:21Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
01:28International Nursing Organizations II
The World Health Organization (WHO) is a specialized agency of the United Nations based in Geneva. The WHO has many initiatives that center around health. Primarily, they lead global efforts to expand universal health coverage using science-based policies and programs. They are also responsible for shaping health research agendas and developing norms and standards.
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...